World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 22 February 2021
Main ID:  ACTRN12616000147482
Date of registration: 08/02/2016
Prospective Registration: Yes
Primary sponsor: Royal Perth Hospital
Public title: The RADICAL project: impact of three different diagnostic tests for patients presenting with chest pain.
Scientific title: Impact of Rapid Access to cardiology Determined multi-modality testing among Individuals presenting with new onset Chest pain: improving quality, efficiency and cost effectiveness at Royal Perth HospitAL: The RADICAL project
Date of first enrolment: 04/05/2016
Target sample size: 500
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12616000147482.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Ms Sonia Kalathil   
Address:  Specialist Chest Pain Nurse Department of Cardiology Royal Perth Hospital 197 Wellington Street Perth, 6000 Western Australia Australia
Telephone: +61 89224 2719
Email: sonia.kalathil@health.wa.gov.au
Affiliation: 
Name: Dr Jonathan Spiro   
Address:  Department of Cardiology Royal Perth Hospital 197 Wellington Street Perth, 6000 Western Australia Australia
Telephone: +61 8 9224 2719
Email: jonathan.spiro@health.wa.gov.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria: age 18–85 years with new onset (<3 months) chest pain, suggestive of stable angina pectoris. Our target population includes patients who live within the RPH postcode-allocated referral areas and patients whom live rurally / remotely who would normally be referred to RPH.
Exclusion criteria: Exclusion criteria: Patients with acute coronary syndrome (ACS) are excluded from this service and should be referred via conventional pathways, such as referral to ED. Other exclusions include: known coronary artery disease, significant cognitive impairment, multiple co-morbidities (involving current input from other clinical specialists), significant valvular heart disease or suspected arrhythmia and advanced renal failure (eGFR <30ml/min). These patients will continue to be assessed in the general cardiology outpatient clinics.

Age minimum: 18 Years
Age maximum: 85 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Coronary artery disease;Angina pectoris;
Coronary artery disease
Angina pectoris
Cardiovascular - Coronary heart disease
Intervention(s)
Patients attending the rapid access chest pain clinic shall be invited to participate. Individuals assessed as being at intermediate risk of significant coronary artery disease shall be randomised to one of three routinely used investigations; exercise treadmill test (ETT), CT coronary angiogram (CTCA) or a myocardial perfusion scan (MPS).

Exercise treadmill test, involves monitoring your heart whilst you walk quickly on a treadmill, similar to those found in a gym. The test is performed by experienced exercise physiologists, within the cardiology department at Royal Perth Hoispital, and usually takes about 10-12 minutes.

CT coronary angiogram; involves an injection of dye into a blood vessel in your arm, whilst an X-ray scan of your heart is performed. Occassionally a single small dose of a medicine (beta blocker) may be given to you in order to slow your heart down to optimise the images. The CT scan takes just a few minutes and is performed by radiologists.

Myocardial perfusion scan; involves an assessment of the blood flow to your heart muscle under conditions of rest and stress (either exercise on a treadmill, or following the injection of a medicine to relax your blood vessels and speed up the flow of blood in your heart (coronary) arteries). This scan involves the injection of a small amount of radioactive tracer. The two scans take about an hour each and are performed on two consecutive days. The scans are performed by radiologists within the Nuclear Medicine department at Royal Perth Hospital.
Primary Outcome(s)
Among patients at intermediate risk of significant coronary artery disease, which investigation is most cost-effective?

This analysis shall be performed by assessing which test most frequently provided the highest diagnostic confidence, therefore removing the need for costly repeated testing. [2 years ]
Among patients at intermediate risk of signifciant coronary artery disease, which investigation improves diagnostic certainty (for angina) at 4 weeks?

'Diagnostic certainty' shall be determined by the physician who reviews the patient in the clinic. The physician shall be asked 'are you certain that the patient's symptoms (angina) are due to coronary artery disease?'; yes, probable, unlikely, or no.

This shall then be repeated at 4 weeks, following reciept of the results of the test performed. We shall then analyse which test, if any, provided the greatest change in diagnostic certainty between these two time points.[4 weeks from initial clinic assessment.]
Secondary Outcome(s)
Compared to current standard practice, does a RACPC improve time from referral to assessment, treatment, diagnosis and revascularisation?

This will be assessed by analysing records of time points (date of referral, date of clinic, date of test, date when medication commenced, date diagnosis made and date of revascularisation if relevant). These time intervals shall then be compared to current (pre-chest pain clinic) standard of care.[Study duration (2 years)]
Compared to current standard practice, does a RACPC reduce cumulative radiation dose per patient?

This will be calculated by analysing the number and types of tests performed on each patient before and after the introduction of the new rapid access chest pain clinic. [2 years ]
Compared to current standard practice, does a RACPC deliver cost savings?

This analysis will be performed in collaboration with the health economics team at the University of Western Australia, and will aim to assess the cost of managing patients before and after the introduction of the rapid access chest pain clinic.

Specifically, we aim to compare the cost of tests performed, costs involved in reviewing patients in the new clinic compared to the original cardiology outpatient clinic, and cost savings that were generated by facilitating earlier discharge of patients from ED and inpatient medical wards and prevention of unplanned hospital presentation and admissions.[2 years ]
Compared to current standard practice, does a RACPC reduce the total number of investigations per patient?

This will be calculated by summing the number of tests performed, in order to achieve a confident diagnosis / management plan, before and after the introduction of the rapid access chest pain clinic.[2 years]
Secondary ID(s)
None
Source(s) of Monetary Support
Department of Health, Western Australia
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 04/05/2016
Contact:
Department of Health Human Research Ethics Committee
Status: Approved
Approval date: 04/05/2016
Contact:
Royal Perth Hospital Human Research Ethics Committee (EC00270)
Status: Not approved
Approval date:
Contact:
Western Australian Aboriginal Health Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history